OFA Group Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by OFA Group on December 17, 2025, for the month of December 2025. The filing addresses a notification received from The Nasdaq Stock Market LLC regarding the Company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance matters rather than financial performance.
Material Changes and Regulatory Status
- Nasdaq Non-Compliance: On December 11, 2025, the Company received notice that its ordinary shares traded below the $1.00 minimum bid price requirement for 30 consecutive business days.
- Compliance Period: The Company has 180 calendar days, until June 9, 2026, to regain compliance. This requires the closing bid price to be at least $1.00 for 10 consecutive business days.
- Trading Status: Shares will continue to trade uninterrupted under the symbol "OFAL" during the compliance period.
- Share Redesignation: Ordinary shares were redesignated as Class A ordinary shares and commenced trading under this classification on December 17, 2025.
Outlook, Risks, and Contingencies
If the Company fails to regain compliance by June 9, 2026, it may be eligible for an additional 180-day grace period. To qualify, the Company must meet the market value of publicly held shares requirement and all other initial listing standards for The Nasdaq Capital Market, excluding the bid price requirement. The Company may need to effect a reverse stock split to cure the deficiency.
Investor Verification Checklist
- Verify the current closing bid price of OFA Group shares to assess progress toward the $1.00 threshold.
- Monitor the Company's announcement regarding any intent to execute a reverse stock split if the initial compliance period expires without success.
- Confirm the continued trading status of the "OFAL" symbol on Nasdaq.
- Review the press release filed as Exhibit 99.1 for additional management commentary on the deficiency.